These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 23027041)
21. PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. Zhu C; Qi X; Chen Y; Sun B; Dai Y; Gu Y J Cancer Res Clin Oncol; 2011 Nov; 137(11):1587-94. PubMed ID: 21904903 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signalling pathway. Bezerra MÉS; Barberino RS; Menezes VG; Gouveia BB; Macedo TJS; Santos JMS; Monte APO; Barros VRP; Matos MHT Reprod Fertil Dev; 2018 Oct; 30(11):1503-1513. PubMed ID: 29843892 [TBL] [Abstract][Full Text] [Related]
23. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. Zheng WH; Quirion R J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184 [TBL] [Abstract][Full Text] [Related]
24. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression. Wang Y; Wang X; Zhao H; Liang B; Du Q J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100 [TBL] [Abstract][Full Text] [Related]
25. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor. Criswell T; Beman M; Araki S; Leskov K; Cataldo E; Mayo LD; Boothman DA J Biol Chem; 2005 Apr; 280(14):14212-21. PubMed ID: 15689620 [TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-I-induced androgen receptor activation is mediated by the PI3K/Akt pathway in C2C12 skeletal muscle cells. Lee WJ Mol Cells; 2009 Nov; 28(5):495-9. PubMed ID: 19855934 [TBL] [Abstract][Full Text] [Related]
27. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Halevy O; Cantley LC Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438 [TBL] [Abstract][Full Text] [Related]
28. Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. Lim DY; Cho HJ; Kim J; Nho CW; Lee KW; Park JH BMC Gastroenterol; 2012 Jan; 12():9. PubMed ID: 22269172 [TBL] [Abstract][Full Text] [Related]
29. Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway. Wang G; Lu M; Yao Y; Wang J; Li J Eur J Pharmacol; 2017 Nov; 814():207-215. PubMed ID: 28847482 [TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells. Wang H; Zhang Q; Zhang L; Little PJ; Xie X; Meng Q; Ren Y; Zhou L; Gao G; Quirion R; Zheng W Neurosci Lett; 2012 May; 516(1):105-9. PubMed ID: 22490886 [TBL] [Abstract][Full Text] [Related]
31. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration. Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695 [TBL] [Abstract][Full Text] [Related]
32. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502 [TBL] [Abstract][Full Text] [Related]
33. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation. Ning J; Clemmons DR Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874 [TBL] [Abstract][Full Text] [Related]
34. Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Tamburini J; Chapuis N; Bardet V; Park S; Sujobert P; Willems L; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D Blood; 2008 Jan; 111(1):379-82. PubMed ID: 17878402 [TBL] [Abstract][Full Text] [Related]
35. Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. Zheng WH; Quirion R BMC Neurosci; 2006 Jun; 7():51. PubMed ID: 16792806 [TBL] [Abstract][Full Text] [Related]
36. Activated phosphatidylinositol 3-kinase/Akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup O-3a signaling. Zhang Z; Zhang T; Zhou Y; Wei X; Zhu J; Zhang J; Wang C Cell Physiol Biochem; 2015; 35(4):1643-53. PubMed ID: 25824462 [TBL] [Abstract][Full Text] [Related]
37. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650 [TBL] [Abstract][Full Text] [Related]
38. Cryptotanshinone inhibits cellular proliferation of human lung cancer cells through downregulation ofIGF-1R/PI3K/Akt signaling pathway. Zhang J; Wen G; Sun L; Yuan W; Wang R; Zeng Q; Zhang G; Yu B Oncol Rep; 2018 Nov; 40(5):2926-2934. PubMed ID: 30106122 [TBL] [Abstract][Full Text] [Related]